Blau Farmacêutica S.A. BLAU3.SA Stock
Blau Farmacêutica S.A. Price Chart
Blau Farmacêutica S.A. BLAU3.SA Financial and Trading Overview
| Blau Farmacêutica S.A. stock price | 10.77 BRL |
| Previous Close | 20.8 BRL |
| Open | 0 BRL |
| Bid | 21.07 BRL x N/A |
| Ask | 21.17 BRL x N/A |
| Day's Range | 0 - 0 BRL |
| 52 Week Range | 0 - 35.58 BRL |
| Volume | 0 BRL |
| Avg. Volume | 439.77K BRL |
| Market Cap | 3.73B BRL |
| Beta (5Y Monthly) | -0.042435 |
| PE Ratio (TTM) | 10.562815 |
| EPS (TTM) | 1.41 BRL |
| Forward Dividend & Yield | 0.73 (3.40%) |
| Ex-Dividend Date | April 20, 2023 |
| 1y Target Est | 31.31 BRL |
BLAU3.SA Valuation Measures
| Enterprise Value | 3.51B BRL |
| Trailing P/E | 10.562815 |
| Forward P/E | 7.671533 |
| PEG Ratio (5 yr expected) | 1.17 |
| Price/Sales (ttm) | 2.7629404 |
| Price/Book (mrq) | 2.0332754 |
| Enterprise Value/Revenue | 2.6 |
| Enterprise Value/EBITDA | 8.561 |
Trading Information
Blau Farmacêutica S.A. Stock Price History
| Beta (5Y Monthly) | -0.042435 |
| 52-Week Change | -18.33% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 35.58 BRL |
| 52 Week Low | 0 BRL |
| 50-Day Moving Average | 20.89 BRL |
| 200-Day Moving Average | 26.89 BRL |
BLAU3.SA Share Statistics
| Avg. Volume (3 month) | 439.77K BRL |
| Avg. Daily Volume (10-Days) | 466.66K BRL |
| Shares Outstanding | 177.68M |
| Float | 29.83M |
| Short Ratio | N/A |
| % Held by Insiders | 82.50% |
| % Held by Institutions | 10.99% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0.688 |
| Trailing Annual Dividend Yield | 3.30% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0.4156 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 26.17% |
| Operating Margin (ttm) | 29.09% |
| Gross Margin | 45.40% |
| EBITDA Margin | 30.37% |
Management Effectiveness
| Return on Assets (ttm) | 10.23% |
| Return on Equity (ttm) | 20.07% |
Income Statement
| Revenue (ttm) | 1.35B BRL |
| Revenue Per Share (ttm) | 7.62 BRL |
| Quarterly Revenue Growth (yoy) | -17.59% |
| Gross Profit (ttm) | 667.88M BRL |
| EBITDA | 410.53M BRL |
| Net Income Avi to Common (ttm) | 353.86M BRL |
| Diluted EPS (ttm) | 1.99 |
| Quarterly Earnings Growth (yoy) | -15.50% |
Balance Sheet
| Total Cash (mrq) | 621.38M BRL |
| Total Cash Per Share (mrq) | 3.49 BRL |
| Total Debt (mrq) | 317.25M BRL |
| Total Debt/Equity (mrq) | 17.3 BRL |
| Current Ratio (mrq) | 4.713 |
| Book Value Per Share (mrq) | 10.338 |
Cash Flow Statement
| Operating Cash Flow (ttm) | 228.55M BRL |
| Levered Free Cash Flow (ttm) | -112063624 BRL |
Profile of Blau Farmacêutica S.A.
| Country | Brazil |
| State | SP |
| City | Cotia |
| Address | Rodovia Raposo Tavares, 2833, km 30,5 |
| ZIP | 06705-030 |
| Phone | 55 11 4615 9400 |
| Website | https://www.blau.com |
| Industry | Drug Manufacturers-Specialty & Generic |
| Sector(s) | Healthcare |
| Full Time Employees | N/A |
Blau Farmacêutica S.A., a pharmaceutical company, engages in the manufacture, development, and commercialization of private label drugs in Brazil, Colombia, Uruguay, Chile, and internationally. It operates through Institutional and Retail segments. The company's medications cover various therapeutic classes, such as immunology, hematology, oncology, nephrology, specialties, and antibiotics. It offers biological drugs; oral and injectable drugs for treating cancer; specialized treatments for infectious diseases; and prescription and non-prescription over-the-counter drugs, including dermo-medicines, condoms, and others for retail and non-retail markets. The company's products also comprise uterine stimulator, antibiotics, feminine health care, biopharmaceuticals, essential hospital products, antivirals and antiretrovirals, biosimilars, acid pump inhibitor, hemoderivados, antithrombotic, and trombolíticos. It serves public and private hospitals, and clinics; and pharmaceutical retail channels. The company was incorporated in 1987 and is headquartered in Cotia, Brazil.
Q&A For Blau Farmacêutica S.A. Stock
What is a current BLAU3.SA stock price?
Blau Farmacêutica S.A. BLAU3.SA stock price today per share is 10.77 BRL.
How to purchase Blau Farmacêutica S.A. stock?
You can buy BLAU3.SA shares on the São Paulo exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Blau Farmacêutica S.A.?
The stock symbol or ticker of Blau Farmacêutica S.A. is BLAU3.SA.
Which industry does the Blau Farmacêutica S.A. company belong to?
The Blau Farmacêutica S.A. industry is Drug Manufacturers-Specialty & Generic.
How many shares does Blau Farmacêutica S.A. have in circulation?
The max supply of Blau Farmacêutica S.A. shares is 191.7M.
What is Blau Farmacêutica S.A. Price to Earnings Ratio (PE Ratio)?
Blau Farmacêutica S.A. PE Ratio is 8.24113500 now.
What was Blau Farmacêutica S.A. earnings per share over the trailing 12 months (TTM)?
Blau Farmacêutica S.A. EPS is 1.41 BRL over the trailing 12 months.
Which sector does the Blau Farmacêutica S.A. company belong to?
The Blau Farmacêutica S.A. sector is Healthcare.
Blau Farmacêutica S.A. BLAU3.SA included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
| IGOVERNANCA IGCX | 19795.8 BRL 4012.28 USD |
-1.32
|
— — | — — | — — | — - | — — |
- {{ link.label }} {{link}}